Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 350

recruiting
3 967
countries
28
conditions
2 124

10 514 trials match your criteria

Cardiac arrest

Not yet recruiting

Acetylcysteine versus glucose placebo for reducing oxidative stress in patients after out‑of‑hospital cardiac arrest (Phase II)

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acetylcysteine

Study of Tozorakimab to Reduce Lung Inflammation and Promote Healing in Patients with COPD

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab

Acute myocardial infarction

Not yet recruiting

Prevention of Left Ventricular Thrombosis in Patients with Acute Anterior Myocardial Infarction Using Fondaparinux plus Standard Drug Combination

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid

Dermatitis atopic

Not yet recruiting

Study of the safety and effectiveness of TRIV-573 injections in adults with moderate to severe atopic dermatitis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years

C3 glomerulopathy

Not yet recruiting

Pegcetacoplan to Prevent Recurrence of C3 Glomerulopathy or Primary Immune‑Complex MPGN in Adolescent and Adult Kidney Transplant Recipients

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pegcetacoplan

Partial seizures

Not yet recruiting

One-Year Open-Label Extension Study Evaluating Safety and Efficacy of Huperzine A as Adjunctive Therapy in Adults with Focal Onset Seizures

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Huperzine A

Colorectal cancer

Not yet recruiting

A phase 1/2 study evaluating safety, pharmacokinetics and efficacy of SOT109 in patients with advanced unresectable or metastatic colorectal cancer

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Schizophrenia

Not yet recruiting

Phase 3 Double‑Blind Relapse Prevention Trial of Trospium Chloride and Xanomeline Tartrate (KarXT) in Adults with Schizophrenia

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride

Non-small cell lung cancer

Not yet recruiting

Phase 1/2 Study of VRN110755 to Assess Safety, Dose and Efficacy in Patients with EGFR‑mutant Non‑Small Cell Lung Cancer

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Anaemia+1

Not yet recruiting

Study of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept

Allergy test positive

Not yet recruiting

Sensitivity and Specificity of Blomia tropicalis Extract, Histamine Dihydrochloride and Sodium Chloride in Skin Prick Test for Patients with Blomia tropicalis Allergy

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Sodium Chloride

Safety and Tolerability of Metformin in Patients with Idiopathic Pulmonary Fibrosis: A Randomized Placebo‑Controlled Phase II Study

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.